company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7047000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7047000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,425000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,102000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,339000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6060000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-121000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-121000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-293000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3006000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9875000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6576000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6576000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:07:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6467000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7274000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7274000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,430000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,107000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,276000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2032000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8493000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8493000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-231000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8571000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8810000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-546000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,88000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-16000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-478000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-478000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8963000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7234000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7234000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,433000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,63000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,439000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-819000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7118000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7118000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-109000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-501000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10750000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10140000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10140000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,8000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,546000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,65186000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,65731000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,65731000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68753000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7317000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7317000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,406000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,160000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,592000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3439000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9598000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9598000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-174000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-67698000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8968000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-58904000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-58904000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-985000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-985000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-985000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-69487000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8644000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8644000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,391000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,211000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,636000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1815000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5591000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5591000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-296000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68384000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18500000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50180000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50180000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,59290000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,59290000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,59290000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:08:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3519000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9866000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9866000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,381000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,417000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,740000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,20377000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12049000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12049000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-689000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38067000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27400000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11356000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11356000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,686000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,686000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,686000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1379000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7088000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7088000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,382000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,447000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,895000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4532000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9896000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9896000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-445000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14565000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24805000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9795000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9795000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,170000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,170000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,170000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,69000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11826000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11826000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,398000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,416000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1188000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,28527000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18703000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18703000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-213000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37658000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20250000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17621000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17621000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1041000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1057000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1057000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2139000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11036000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11036000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,400000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,534000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,991000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1441000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10552000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10552000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-436000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-93876000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24500000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-69812000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-69812000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,79579000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,79579000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,79579000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 06:04:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-785000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11474000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11474000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,423000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,508000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1212000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-328000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9659000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9659000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-980000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9118000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23000000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12902000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12902000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-886000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2257000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1371000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1371000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4614000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23971000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23971000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,452000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,449000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2856000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4065000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24279000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24279000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-98000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32382000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73750000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41270000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41270000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3126000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2257000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,869000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,869000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17860000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,296128000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,296128000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,403000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,534000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9533000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26990000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,333588000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,333588000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-912000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-322682000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,101000000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-222594000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-222594000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2021000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2021000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2021000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,113015000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13040000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13040000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,375000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1119000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6168000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-28730000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34108000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34108000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-823000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100665000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,118250000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16762000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16762000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2755000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2369000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,386000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,386000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16960000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 06:05:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14701000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13137000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13137000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,407000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1227000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5817000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9372000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15058000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15058000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1045000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-239215000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,156000000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-84260000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-84260000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3161000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1300000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4461000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4461000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-94857000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19414000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19414000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,451000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,993000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10200000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7894000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15664000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15664000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-253000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-71075000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,116750000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,45422000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,45422000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,786000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12323000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11537000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11537000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18221000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20106000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20106000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,509000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,848000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13832000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10004000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14921000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14921000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-840000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-105797000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75000000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31637000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31637000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1621000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3785000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2164000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2164000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48722000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-3268000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33443000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33443000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,515000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,708000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9887000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5596000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27929000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27929000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1824000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125701000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,205750000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,78225000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,78225000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10765000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10765000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10765000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:18:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39531000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44286000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44286000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,597000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,515000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9763000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4323000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29088000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29088000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-757000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-94951000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,12000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,136500000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40804000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40804000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,809000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,809000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,809000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12525000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43282000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43282000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,619000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,244000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7064000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7651000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27704000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27704000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1046000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98212000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,104750000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5492000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5492000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1049000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1049000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1049000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23261000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29211000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29211000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,782000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,154000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7554000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6742000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27463000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27463000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1314000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11499000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62500000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,49687000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,49687000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4022000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2904000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1118000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1118000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23342000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1704000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20390000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20390000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1151000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7825000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,779000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10622000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10622000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-840000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-153957000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,63250000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-91547000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-91547000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,109317000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-997000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,108320000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,108320000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:31:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6151000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34060000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34060000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1305000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-349000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7435000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2712000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28381000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28381000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9893000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58190000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,82250000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14167000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14167000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1159000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-101000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1058000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1058000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13156000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47244000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47244000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1273000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-648000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7634000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8052000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30933000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30933000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-414000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-70296000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,113500000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,42790000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,42790000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,160000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-757000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-597000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-597000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11260000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38753000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38753000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1291000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-766000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6612000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20962000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-52578000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-52578000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-184000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-94922000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,127200000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,32094000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,32094000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,939000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-547000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,392000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,392000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20092000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35385000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35385000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1331000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-778000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5218000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3062000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32676000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32676000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-983000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59714000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,79500000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18803000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18803000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,222000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-670000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-448000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-448000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:19:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14321000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34391000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34391000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1333000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-668000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5576000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4496000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23654000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23654000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-653000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65374000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97642000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31615000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31615000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,771000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-58000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,713000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,713000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8674000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36069000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36069000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1186000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-479000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8337000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-892000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27917000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27917000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,58000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-55463000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94650000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,39245000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,39245000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-706000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-701000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-701000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10627000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31357000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31357000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1463000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-238000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5089000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4576000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29619000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29619000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-198000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12512000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49223000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,36513000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,36513000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,138000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-165000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-27000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-27000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6867000.0
